Drug Interaction in Infectious Diseases

The medical harm which can be majorly prevented is drug interactions in the infectious diseases. Drug interactions represent a major risk to patients. The approved drug product labels for anti-infective drugs, direct-acting antivirals for HCV, HIV drugs unveil that drug interactions present a huge challenge for patients and their healthcare providers. Non-CYP enzymes, CYP enzymes, and changes in gastric pH, the ever-growing list of drug transporters may be the cause of interactions. There are other considerations which incorporate interactions due to food components, herbal medications and biological products.

    Related Conference of Drug Interaction in Infectious Diseases

    April 14-15, 2025

    15th European Epidemiology and Public Health Congress

    Budapest, Hungary
    June 02-03, 2025

    14th World Congress on Rare Diseases and Orphan Drugs

    Amsterdam, Netherlands
    June 02-03, 2025

    17th Euro-Global Conference on Infectious Diseases

    Amsterdam, Netherlands
    August 28-29, 2025

    8th Pathology and Infectious Disease Conference

    London, UK
    September 22-23, 2025

    11th International Conference on Infectious and Rare Diseases

    Vancouver, Canada
    December 11-12, 2025

    8th Annual Congress on Bacterial, Viral and Infectious Diseases

    Prague, Czech Republic

    Drug Interaction in Infectious Diseases Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in